HomeTLSIW • NASDAQ
add
TriSalus Life Sciences Inc
Previous close
$1.56
Year range
$0.42 - $5.00
Market cap
267.06M USD
Avg Volume
3.58K
P/E ratio
-
Dividend yield
-
In the news
TLSI
6.39%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 13.20M | 59.85% |
Operating expense | 14.71M | -10.10% |
Net income | -9.75M | 3.51% |
Net profit margin | -73.86 | 39.64% |
Earnings per share | -0.05 | 87.48% |
EBITDA | -3.14M | 65.55% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 20.44M | 139.75% |
Total assets | 35.33M | 47.39% |
Total liabilities | 69.19M | 38.76% |
Total equity | -33.86M | — |
Shares outstanding | 61.31M | — |
Price to book | -2.29 | — |
Return on assets | -22.78% | — |
Return on capital | -204.98% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -9.75M | 3.51% |
Cash from operations | -2.48M | 56.47% |
Cash from investing | -41.00K | 18.00% |
Cash from financing | 277.00K | -90.75% |
Net change in cash | -2.25M | 18.64% |
Free cash flow | -10.13M | -170.92% |
About
Founded
2009
Headquarters
Website
Employees
110